Steven A Shallcross - Net Worth and Insider Trading
Steven A Shallcross Net Worth
The estimated net worth of Steven A Shallcross is at least $900,000 dollars as of 2024-08-24. Steven A Shallcross is the CEO and CFO of Theriva Biologics Inc and owns about 250,000 shares of Theriva Biologics Inc (TOVX) stock worth over $900,000. Details can be seen in Steven A Shallcross's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steven A Shallcross has not made any transactions after 2023-06-07 and currently still holds the listed stock(s).
Transaction Summary of Steven A Shallcross
Steven A Shallcross Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven A Shallcross owns 5 companies in total, including Elys Bmg Group Inc (ELYS) , Theriva Biologics Inc (TOVX) , and Nuo Therapeutics Inc (AURX) among others .
Click here to see the complete history of Steven A Shallcross’s form 4 insider trades.
Insider Ownership Summary of Steven A Shallcross
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ELYS | Elys Bmg Group Inc | 2019-06-13 | director |
TOVX | Theriva Biologics Inc | 2023-06-07 | director & CEO and CFO |
AURX | Nuo Therapeutics Inc | 2013-03-30 | SEE REMARKS |
![]() | ![]() | 2006-04-12 | Sr. VP & CFO & Treasurer |
![]() | ![]() | 2021-07-20 | director |
Steven A Shallcross Latest Holdings Summary
Steven A Shallcross currently owns a total of 1 stock. Steven A Shallcross owns 250,000 shares of Theriva Biologics Inc (TOVX) as of June 7, 2023, with a value of $900,000.
Latest Holdings of Steven A Shallcross
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TOVX | Theriva Biologics Inc | 2023-06-07 | 250,000 | 3.60 | 900,000 |
Holding Weightings of Steven A Shallcross
Steven A Shallcross Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven A Shallcross has made a total of 7 transactions in Theriva Biologics Inc (TOVX) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Theriva Biologics Inc is the acquisition of 14,000 shares on June 7, 2023, which cost Steven A Shallcross around $9,660.
Insider Trading History of Steven A Shallcross
- 1
Steven A Shallcross Trading Performance
GuruFocus tracks the stock performance after each of Steven A Shallcross's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven A Shallcross is -10.69%. GuruFocus also compares Steven A Shallcross's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven A Shallcross within 3 months outperforms 1 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven A Shallcross's insider trading performs compared to the benchmark.
Performance of Steven A Shallcross
Steven A Shallcross Ownership Network
Ownership Network List of Steven A Shallcross
Ownership Network Relation of Steven A Shallcross
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Steven A Shallcross Owned Company Details
What does Elys Bmg Group Inc do?
Who are the key executives at Elys Bmg Group Inc?
Steven A Shallcross is the director of Elys Bmg Group Inc. Other key executives at Elys Bmg Group Inc include 10 percent owner Gold Street Capital Corp. , director & 10 percent owner & Chief Executive Officer Michael Ciavarella , and Interim CFO Carlo Reali .
Elys Bmg Group Inc (ELYS) Insider Trades Summary
Over the past 18 months, Steven A Shallcross made no insider transaction in Elys Bmg Group Inc (ELYS). Other recent insider transactions involving Elys Bmg Group Inc (ELYS) include a net purchase of 3,322,915 shares made by Gold Street Capital Corp. , and a net purchase of 1,942,345 shares made by Michael Ciavarella .
In summary, during the past 3 months, insiders sold 0 shares of Elys Bmg Group Inc (ELYS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elys Bmg Group Inc (ELYS) were sold and 5,265,260 shares were bought by its insiders, resulting in a net purchase of 5,265,260 shares.
Elys Bmg Group Inc (ELYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Elys Bmg Group Inc Insider Transactions
Steven A Shallcross Mailing Address
Above is the net worth, insider trading, and ownership report for Steven A Shallcross. You might contact Steven A Shallcross via mailing address: C/o Elys Game Technology Corp., 130 Adelaide Street West, Suite 701, Toronto A6 M5h2k4.